It is necessary to have a dramatic increase in the number of rapid tests for COVID-19 conducted on a large number of people and that should become the basis for estimating the morbidity and mortality due to COVID-19, not relying only on hospital reports, says Professor K Srinivasan.

Rediff reader K Srinivasan, 54 who works as associate general manager, corporate relations at BGS Gleneagles Global Hospitals in Bengaluru shares his story.